Global Markets Direct Market Research Reports

TITLE Actions
Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Drugs In Development, 2021, provides an over...

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Drugs In Development, 2021, provides an overview of the...

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis - Drugs In Developm...

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021, provides an overview of...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia - ...

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia - Drugs In Development, 2021...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia - Dr...

Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 2021, provides an overview...

Chondrosarcoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Chondrosarcoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Drugs In Development, 2021, provides an overview of the Chon...

Ewing Sarcoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Ewing Sarcoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Drugs In Development, 2021, provides an overview of the Ewing ...

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Anaplastic Astrocytoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Drugs In Development, 2021, provides an over...

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma - Drugs In Development, 2021, provid...

Gliosarcoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Gliosarcoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an overview of the Gliosarcom...

Pontine Glioma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Pontine Glioma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides an overview of the Pont...

Neuroblastoma (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Neuroblastoma (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides an overview of the Neurob...

Gallbladder Cancer (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Gallbladder Cancer (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Drugs In Development, 2021, provides an overview of ...

Cervical Cancer (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Cervical Cancer (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provides an overview of the Ce...

Endometrial Cancer (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2500 Onwards | By Global Markets Direct

Endometrial Cancer (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2021, provides an overview of ...

Vaginal Cancer (Oncology) - Drugs in Development, 2021
Published in Oct 2021 | US $ 2000 Onwards | By Global Markets Direct

Vaginal Cancer (Oncology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides an overview of the Vagi...

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Drugs in Development, 2021 Summary Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which a...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K